Table 1 Examinations and collected data
Examination type | Examination time | Collected data |
|---|---|---|
Screening | Before implantation; every patient eligible for the study regardless of his/her participation in the trial | Checking of the inclusion/exclusion criteria |
Implantation | Before inclusion in clinical trial | |
Pretreatment examination | Before randomization | Clinical control of implant site; informed consent |
Baseline: second-stage surgery and insertion of first abutment | 90 ± 14 days after implantation | Tissue sampling (control punch biopsy) |
Photo documentation | ||
X-ray control | ||
PICF sampling | 7, 14, 21, and 28 (±1) days after insertion of the first, second, and third abutment | PICF sampling |
Plaque Index (PI) | ||
Gingival Index (GI) | ||
Probing depth (PD) | ||
Bleeding on probing (BOP) | ||
Tissue sampling and insertion of second and third abutments | 2–5 days after the last PICF sampling around the first, second, and third abutment | Tissue sampling (ring biopsy) |